安娜情欲史

A |     Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。        美国总统特朗普8月21日说了一句话，让全世界金融圈炸了锅。    在被记者问到“面对美国长期债券收益率再回升还有什么干预手段”时，特朗普脱口而出：“终极干预手段是美军，如果需要，将出动美军。”    救市救到要出动军队，美国国债这是出了多大的事？    先看数据。8月19日，美国财政部发布了一个“不祥的里程碑”——美国联邦政府债务总额首次突破40万亿美元。截至8月18日，未偿还公共债务总额达到40.047万亿美元，比美国2025年GDP还多出近10万亿美元。

B | 2026财年前九个月净利息支出已达8270亿美元，超过国防支出。    更扎心的是，全球债主们正在用脚投票。    美国财政部8月18日公布的国际资本流动报告显示，6月份海外投资者美债持有量较5月减少721亿美元。过去4个月里，海外持仓已有3个月下滑，总持有量降至9.299万亿美元。

C |     谁在带头跑？ 日本，美国最大的海外债主。6月份单月减持264亿美元，持仓降至1.1167万亿美元。从2月到6月，日本4个月减持超1200亿美元。    英国也没闲着，6月减持87亿美元，持仓降至9399亿美元。中国6月减持259亿美元，持仓降至6334亿美元，创2008年9月以来最低水平。过去4个月里，中国合计减持超600亿美元。

D | 美国前八大海外债主中，有六个在6月集体减持。    盟友们在集体“叛变”——日本卖美债救日元，中国持续多元化外汇储备，英国跟着跑。而特朗普这边，财政部的“救市”操作已经宣告失败。        美国财政部8月20日宣布将长期国债回购规模“至少扩大一倍”，贝森特甚至暗示可能进一步扩大。结果呢？30年期美债收益率短暂回落后直接反弹，8月21日盘中一度升至5.27%，创2007年以来新高。

E | 市场用脚投票，告诉白宫：这点回购，不够。    更麻烦的是，美国财政部的回购计划本身就有“天花板”——根据现行法律，财政部回购国债需要国会授权额度。

F | 如果大规模回购导致财政赤字进一步扩大，反而会加剧市场对美债信用的担忧。

G |         桥水基金创始人达利欧已经发出警告：按照当前路径，美国债务危机最早1年、最晚5年就会爆发，“如果维持现有路线不变，危机大概率将在3年左右到来”。他建议投资者减持债券，配置10%到15%的黄金，再持有“少量”比特币。

H |     回到特朗普那句“出动美军”。

I | 网友的评论很直接：“特朗普的意思是，只要挑起一场真正的全面战争，就能逼出避险买盘给美债接盘。”还有人调侃：“美国这是想直接占领头号持债国日本，然后把欠他们的债一笔勾销吗？”    玩笑归玩笑，但“美军干预美债”这句话从一个美国总统嘴里说出来，本身就是美国信用正在崩塌的信号。当全球最大的债务国开始用军事威胁来给自己的国债找买家时——这场40万亿美元的债务游戏，离终局还有多远？    主要信息源：    https://news.sina.com.cn/c/2026-08-22/doc-inipavkk1253909.shtml返回，查看更多。